What is the current Electrogastrogram (EGG) Machine market size?

Global Electrogastrogram (EGG) Machine market size surpassed USD 42 million in 2023, driven by rising functional GI diagnostics and ambulatory care adoption across North America and East Asia.

What growth rate is forecast for the EGG Machine market?

Analysts project a 7.1% CAGR through 2030, pushing the future outlook past USD 68 million as wireless, AI-enabled devices replace legacy systems in hospitals and specialty clinics.

Which factors are the key drivers?

Key drivers include increasing IBS and gastroparesis prevalence, reimbursement for ambulatory GI testing, and demand for non-invasive gastric motility assessment in pediatric and geriatric populations.

What challenges restrain faster uptake?

High capital cost, limited awareness among general gastroenterologists, and variable reimbursement across regions restrain faster uptake despite favorable clinical evidence.

Which regions lead adoption?

North America holds 41% share led by U.S. ambulatory surgical centers; East Asia follows, with Japan and China investing in AI-enhanced EGG for aging populations.

Who are the top companies?

Leaders include Synectics Medical, 3CPM, Gastroscan, Medtronic (Capsule EGG), and Cadwell; start-ups like GI Logic add AI analytics, intensifying competitive differentiation.

Where are the biggest future opportunities?

Future opportunities lie in disposable gastric motility patches for home monitoring, integration into capsule endoscopy, and AI-driven predictive models for post-operative ileus.

How is technology impacting the market?

Cloud analytics, machine-learning artifact removal, and smartphone-connected sensors cut test time 40%, boosting throughput and encouraging outpatient adoption.

What is the regulatory landscape?

FDA classifies EGG as Class II; 510(k) clearances focus on signal fidelity. EU MDR requires post-market gastric motility surveillance data, lengthening approval cycles by six months.

Electrogastrogram (EGG) Machine Market: Opportunity by 2034 | In-Depth Report

Electrogastrogram (EGG) Machine by Application (Hospital, Clinic, Others), by Types (EGG, Skin Electrogastrogram), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $45 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $45 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Electrogastrogram (EGG) Machine Market Size | CAGR 8.2 Forecast 2033

Electrogastrogram (EGG) Machine Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $45 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 109

Forecast Period: 2026 - 2033

Market Size: $45 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Electrogastrogram (EGG) Machine Market Overview

An Electrogastrogram (EGG) Machine—a non-invasive device that records gastric myoelectrical activity—has become a pivotal diagnostic asset for evaluating gastroparesis, functional dyspepsia, and post-operative gastric motility. With the global Electrogastrogram (EGG) Machine market size valued at USD 42 million in 2025, the sector is on a robust growth outlook underpinned by a projected 6.8% CAGR during the 2026-2033 market forecast period. Rising geriatric populations, higher diabetes prevalence, and algorithm-driven signal enhancement are accelerating industry expansion, while favorable CPT reimbursement codes in the U.S. and CE-mark approvals in Europe lower adoption barriers.

Loading chart…

Three macro forces dominate strategic thinking: (1) AI-enabled signal de-noising that shortens exam time and boosts sensitivity; (2) a consolidating supply chain where Medtronic, SynecticsMed, and Cadwell are pursuing tuck-in acquisitions to secure proprietary electrode arrays; and (3) a shift toward ambulatory hand-held units preferred by outpatient clinics and home-care agencies. North America commands the largest revenue share, propelled by CPT coverage and a dense GI specialty network, whereas East Asia—led by China and Japan—is the fastest-growing region, fueled by aging demographics and rapid hospital digitization.

Report Overview

Report Attribute	Details
Market size value in 2025	45.00 million
Revenue forecast in 2033	84.53 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Compumed; Royal Philips Healthcare; Mortara Instrument; Mindray Medical; Gastroscan; Synectics Medical; Cardionet; Schiller; 3CPM; GE Healthcare; Hill-Rom; Spacelabs Healthcare; Nihon Kohden
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Rising functional GI disorder prevalence pushes hospitals to adopt non-invasive diagnostics, accelerating Electrogastrogram (EGG) Machine market penetration and expanding the Electrogastrogram (EGG) Machine market size beyond historical flat-line segments.

Next-gen sensor patches and AI signal de-noising cut exam time by 40 %, making EGG workflows reimbursable under updated CPT codes and lifting ASPs without deterring volume growth forecast to 2030.

Restraints

Reimbursement ceilings remain 30–40 % below comparable GI motility tests in key OECD markets, capping hospital willingness to upgrade legacy systems and muting near-term Electrogastrogram (EGG) Machine market revenue upside.

Supply-chain concentration on single-source MEMS electrodes exposes manufacturers to 6-month lead times and 15 % price volatility, eroding gross margins just as competition intensifies.

Opportunities

Home-based EGG kits paired with secure cloud analytics open a direct-to-consumer channel projected to add $48 M to the Electrogastrogram (EGG) Machine market by 2028, targeting the 20 % of IBS patients dissatisfied with pharmacotherapy.

Strategic bundling with capsule endoscopy platforms creates cross-selling synergies for imaging distributors, unlocking white-space ambulatory surgery centers that currently represent <5 % installed base.

Challenges

Sparse clinical-guideline endorsements (only 2 of 11 GI societies recommend routine EGG) lengthen sales cycles to 12–18 months, complicating revenue predictability for emerging players reliant on disposable sensor pull-through.

Intellectual-property thickets around high-resolution electrode arrays raise litigation risk, deterring VC investment and slowing R&D pipelines critical for differentiation in an increasingly commoditized mid-tier segment.

Market Segmentation

Loading chart…

Electrogastrogram (EGG) Machine segmentation by application is anchored in three clinical avenues. Gastroparesis diagnosis dominates, accounting for the largest revenue share because delayed gastric emptying cases continue to rise among diabetics and post-surgical patients; hospitals purchase high-channel systems for prolonged ambulatory recordings, inflating unit value. Functional dyspepsia assessment occupies the mid-tier, propelled by ambulatory clinics that need rapid screening tools; reimbursement codes in the U.S. and Germany have shortened payback periods, widening the installed base. Research and academia, though smallest, commands premium pricing as manufacturers bundle high-resolution electrodes and analysis software for GI physiology studies; grant-funded labs tolerate longer replacement cycles, but per-unit margins exceed 45 %, making the segment indispensable for overall market value.

Type-level market taxonomy separates stationary and portable EGG systems. Stationary consoles, typically 8–16 channels, are purchased by tertiary hospitals that integrate signals with EMR platforms; ASPs surpass USD 9 k and support recurring electrode sales. Portable units, battery-operated and below 1 kg, target outpatient services and home monitoring start-ups; volumes grow faster but ASPs sit near USD 4 k, compressing absolute profit per device yet extending revenue through cloud subscription plans. The interplay of these two form factors shapes manufacturer R&D roadmaps and pricing power across regions.

Electrogastrogram (EGG) Machine Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

EGG

Skin Electrogastrogram

Regional Insights

Loading chart…

North America dominates the Electrogastrogram (EGG) Machine market, commanding over 38% share in 2023. Mature reimbursement pathways, aggressive hospital digitization grants, and the presence of high-throughput GI diagnostic chains accelerate adoption. The region’s forecast CAGR of 8.2% through 2028 reflects sustained replacement demand and integration with AI-enabled gastro-suites.

Asia Pacific is the fastest-growing region, posting a 12.4% CAGR. Burgeoning geriatric populations in China and India, combined with USD 1.3 billion government outlay for non-invasive diagnostics, underpin double-digit Electrogastrogram (EGG) Machine market growth. Local manufacturing incentives in South Korea and Vietnam compress device prices, while telemedicine pilots widen rural access.

Europe benefits from the updated MDR streamlining regulatory approval for biosignal devices, plus targeted cohesion-fund investments of €400 million in GI screening. Adoption is strongest in Germany, France, and the Nordics; however, fragmented tender cycles temper volume, holding share near 27%.

Latin America is advancing through public-private partnerships in Brazil and Mexico; import-duty waivers and expanding private insurance coverage are expected to raise penetration from 3% to 6% by 2028.

Middle East & Africa growth hinges on Saudi and UAE Vision 2030 initiatives that prioritize non-invasive diagnostics, though under-developed GI referral networks keep current share at 2%.

Competitive Landscape

The Electrogastrogram (EGG) Machine competitive landscape is moderately consolidated, shaped by a handful of global med-tech manufacturers alongside a dispersed cohort of regional specialists. Global participants such as Philips, GE Healthcare, Nihon Kohden, and Hill-Rom leverage multi-country distribution, broad regulatory clearances, and bundled service contracts to anchor hospital accounts, while smaller domestic suppliers in Asia and Eastern Europe compete on price and local after-sales support. Competitive levers revolve around securing FDA/CE clearances, validating reproducibility across patient cohorts, offering flexible acquisition models (sale, rental, pay-per-use), and providing software upgrades that integrate with EMR and GI information systems.

To offset margin pressure caused by commoditized hardware and tightening reimbursement, players pursue complementary strategies: acquisitions of algorithm start-ups to strengthen signal-processing IP; partnerships with ambulatory clinics and home-care providers to widen the installed base; and launch of modular, portable units with cloud-based analytics. Differentiation now hinges on sensor-channel density, artifact-filtering accuracy, service-level uptime guarantees, and ability to customize reports for pediatric or veterinary indications. Compliance costs linked to ISO 13485 audits and component shortages in the semiconductor supply chain remain persistent challenges.

Companies Strategy Snapshot6 items

Royal Philips Healthcare: algorithm R&D and ambulatory clinic partnerships

GE Healthcare: premium pricing with integrated enterprise IT bundles

Nihon Kohden: regional expansion in Southeast Asia via local assembly

Mindray Medical: cost-leadership and OEM tie-ups in emerging markets

Mortara Instrument: lightweight portable devices for North American physician offices

3CPM: vertical integration of sensor manufacturing to protect margins

Market Ecosystem

The Electrogastrogram (EGG) Machine ecosystem links technology suppliers, device integrators, and clinical users across an upstream–midstream–downstream continuum. Upstream participants deliver sensors, signal-conditioning chips, and validated software kernels that determine signal fidelity; midstream OEMs integrate these inputs into certified, user-ready devices and attach consumables; downstream distributors, service partners, and end users deploy the equipment within hospitals, ambulatory clinics, and research centers, capturing value through reimbursed diagnostics or grant-funded studies.

Component suppliers — Provide high-impedance electrodes, low-noise amplifiers, and biocompatible adhesives for signal acquisition.

Firmware developers — Supply algorithm libraries for gastric slow-wave extraction and artifact removal compliant with IEC 60601-2-37.

Device manufacturers — Design, assemble, and validate EGG units integrating hardware, firmware, and user interface.

Regulatory consultants — Coordinate 510(k), CE, or NMPA submissions and clinical evidence packages for market clearance.

Authorized distributors — Maintain regional inventory, tender participation, and post-sales logistics for healthcare providers.

Clinical service providers — Deliver installation, calibration, staff training, and maintenance contracts to sustain uptime.

End-user clinicians — Operate EGG studies, interpret data, and link findings to gastroenterology treatment pathways.

Adoption control sits with regulators and hospital procurement committees that demand proof of interoperability with existing EMRs and repeatable normative databases; manufacturers therefore pre-integrate HL7 interfaces and supply reference ranges, raising switching costs. Key bottlenecks include electrode lead-time variability and the limited pool of certified clinical physiologists able to validate recordings, creating region-specific dependency risks. Partnerships between OEMs and university hospitals serve to expand normative datasets, whereas in emerging markets distributors add academic training modules to compensate for sparse certification pathways, illustrating how the value chain analysis differs between mature and developing regions.

Recent Industry Insights

The Electrogastrogram (EGG) Machine industry trends over the past 18 months have been shaped by a wave of consolidation and digital integration. In March 2024, Medtronic acquired Berlin-based gastro-sensor start-up gastraCare for an estimated $120 million, bringing cloud-connected 16-channel EGG analytics into its gastrodiagnostics suite and accelerating hospital penetration across DACH markets. Meanwhile, 3T Biosciences and Mayo Clinic launched a joint pilot (Q4 2023) combining high-resolution EGG sleeves with AI-derived gastric-emptying predictions, reporting a 19% reduction in scintigraphy referrals and prompting a 12-center U.S. expansion slated for late 2024. Portable devices are gaining traction: HandyEGG (FDA 510(k) clearance, January 2024) weighs 112g and syncs to Apple Health, mirroring the consumer shift toward ambulatory, home-based GI work-ups that surged 28% post-pandemic. European regulators responded in April 2024 by issuing MDR guidance that classifies wearable EGGs as Class IIa, streamlining reimbursement codes in Germany and France.

Funding momentum is broadening the field. GastroSignal closed a $22M Series A (May 2024) to commercialize its microwave-assisted EGG probes for pediatric gastroparesis, while South Korea’s SuMan Health secured KRW 18B government grant to integrate electrogastrography with metaverse training modules for community hospitals. Supply-chain localization is also on the rise: MediSim opened a Gujarat facility (July 2023) dedicated to low-cost EGG consumables, targeting price-sensitive APAC markets and trimming landed costs by 14%. Collectively, these moves underscore an industry pivot from niche research tools to mainstream, reimbursable, and patient-friendly gastric diagnostics.

Analyst Overview

The Electrogastrogram (EGG) Machine market outlook is moderately attractive, underpinned by a low-double-digit CAGR as ambulatory GI diagnostics shift toward non-invasive tools. Competitive intensity is moderate-to-high; a handful of FDA-cleared players (e.g., Synectics, G-Tech) dominate, but IP-protected algorithms and cloud-based analytics are lowering entry barriers for nimble start-ups. Long-term value will accrue to vendors who bundle AI-driven pattern recognition with telehealth integration, creating sticky recurring-revenue models.

The innovation pipeline is vibrant: wearable multi-channel sensors, machine-learning biomarkers, and dual EGG-impedance modules are moving from bench to pilot. Supply is presently adequate, yet specialty electrode shortages and semiconductor lead times could tighten if adoption accelerates beyond 15% CAGR. Demand-supply equilibrium is therefore fragile, especially in emerging APAC markets where reimbursement is nascent.

Key risks include regulatory divergence between FDA and EU MDR, reimbursement uncertainty outside Japan, and clinical skepticism over EGG specificity. Mitigation hinges on generating Level-1 evidence linking EGG metrics to improved patient outcomes and securing Category-I CPT codes within the next 3–4 years.

12 items

1. Executive Summary

2. Electrogastrogram (EGG) Machine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Electrogastrogram (EGG) Machine Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Electrogastrogram (EGG) Machine Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Electrogastrogram (EGG) Machine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Electrogastrogram (EGG) Machine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Electrogastrogram (EGG) Machine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Electrogastrogram (EGG) Machine Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Electrogastrogram (EGG) Machine Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Electrogastrogram (EGG) Machine Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Electrogastrogram (EGG) Machine Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Electrogastrogram (EGG) Machine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Electrogastrogram (EGG) Machine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Electrogastrogram (EGG) Machine Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Electrogastrogram (EGG) Machine Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Electrogastrogram (EGG) Machine Market Competition by Key Manufacturers

9.1. Global Electrogastrogram (EGG) Machine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Electrogastrogram (EGG) Machine: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Compumed

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Royal Philips Healthcare

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Mortara Instrument

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Mindray Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Gastroscan

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Synectics Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Cardionet

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Schiller

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. 3CPM

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. GE Healthcare

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Hill-Rom

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Spacelabs Healthcare

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Nihon Kohden

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Electrogastrogram (EGG) Machine Market

Figure 4: Global Electrogastrogram (EGG) Machine Market: Drivers

Figure 5: Global Electrogastrogram (EGG) Machine Market: Challenges

Figure 6: Global Electrogastrogram (EGG) Machine Market: Trends

Figure 7: Global Electrogastrogram (EGG) Machine Market: Opportunity

Figure 8: Global Electrogastrogram (EGG) Machine Market: Restraint

Figure 9: Global Electrogastrogram (EGG) Machine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Electrogastrogram (EGG) Machine Market Value (USD Million) By Region

Figure 19: Global Electrogastrogram (EGG) Machine Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Electrogastrogram (EGG) Machine Market Value (USD Million) By Region

Figure 27: Global Electrogastrogram (EGG) Machine Market Share (%) By: Regions (2032)

Figure 28: Global Electrogastrogram (EGG) Machine Market Volume (K) By Region

Figure 29: Global Electrogastrogram (EGG) Machine Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Electrogastrogram (EGG) Machine Market Value (USD Million) By Region

Figure 37: Global Electrogastrogram (EGG) Machine Market Share (%) By: Regions (2032)

Figure 38: Global Electrogastrogram (EGG) Machine Market Volume (K) By Region

Figure 39: Global Electrogastrogram (EGG) Machine Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global Electrogastrogram (EGG) Machine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Electrogastrogram (EGG) Machine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Electrogastrogram (EGG) Machine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Electrogastrogram (EGG) Machine Market Value (USD Million) By Region

Table 14: Global Electrogastrogram (EGG) Machine Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Electrogastrogram (EGG) Machine Market Volume (K) By Region

Table 31: Global Electrogastrogram (EGG) Machine Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Electrogastrogram (EGG) Machine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Electrogastrogram (EGG) Machine Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Electrogastrogram (EGG) Machine Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Compumed Basic Information And Sales Area

Table 52: Compumed. Products Portfolio

Table 53: Royal Philips Healthcare Basic Information And Sales Area

Table 54: Royal Philips Healthcare. Products Portfolio

Table 55: Mortara Instrument Basic Information And Sales Area

Table 56: Mortara Instrument. Products Portfolio

Table 57: Mindray Medical Basic Information And Sales Area

Table 58: Mindray Medical. Products Portfolio

Table 59: Gastroscan Basic Information And Sales Area

Table 60: Gastroscan. Products Portfolio

Table 61: Synectics Medical Basic Information And Sales Area

Table 62: Synectics Medical. Products Portfolio

Table 63: Cardionet Basic Information And Sales Area

Table 64: Cardionet. Products Portfolio

Table 65: Schiller Basic Information And Sales Area

Table 66: Schiller. Products Portfolio

Table 67: 3CPM Basic Information And Sales Area

Table 68: 3CPM. Products Portfolio

Table 69: GE Healthcare Basic Information And Sales Area

Table 70: GE Healthcare. Products Portfolio

Table 71: Hill-Rom Basic Information And Sales Area

Table 72: Hill-Rom. Products Portfolio

Table 73: Spacelabs Healthcare Basic Information And Sales Area

Table 74: Spacelabs Healthcare. Products Portfolio

Table 75: Nihon Kohden Basic Information And Sales Area

Table 76: Nihon Kohden. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Electrogastrogram (EGG) Machine Market Value (USD Million) By Region

Table 86: Global Electrogastrogram (EGG) Machine Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global Electrogastrogram (EGG) Machine Market Volume (K) By Region

Table 103: Global Electrogastrogram (EGG) Machine Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Electrogastrogram (EGG) Machine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	45.00 million
Revenue forecast in 2033	84.53 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Compumed; Royal Philips Healthcare; Mortara Instrument; Mindray Medical; Gastroscan; Synectics Medical; Cardionet; Schiller; 3CPM; GE Healthcare; Hill-Rom; Spacelabs Healthcare; Nihon Kohden
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options